Related Experiment Videos
Adjuvant therapy by BCG of non-Hodgkin's malignant lymphomas in a controlled trial: an update
British Journal of Haematology
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Checkpoint inhibitors in metastatic papillary renal cell carcinoma.
Cancer treatment reviews·2021
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Asia-Pacific journal of clinical oncology·2020
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
How to report toxicity associated with targeted therapies?
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.
British journal of haematology·2026
CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.
British journal of haematology·2026
RESOLVE to do better.
British journal of haematology·2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.
British journal of haematology·2026